menu
    • menu
    [{"orgOrder":0,"company":"Sprint Bioscience","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"SWEDEN","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"SB02024","moa":"VPS3A","graph1":"Oncology","graph2":"Preclinical","graph3":"Sprint Bioscience","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Sprint Bioscience \/ Inapplicable","highestDevelopmentStatusID":"4","companyTruncated":"Sprint Bioscience \/ Inapplicable"},{"orgOrder":0,"company":"Sprint Bioscience","sponsor":"Day One Biopharmaceuticals","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"SWEDEN","productType":"Undisclosed","year":"2023","type":"Licensing Agreement","leadProduct":"Undisclosed","moa":"VRK1","graph1":"Oncology","graph2":"Preclinical","graph3":"Sprint Bioscience","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Oral","sponsorNew":"Sprint Bioscience \/ Day One Biopharmaceuticals","highestDevelopmentStatusID":"4","companyTruncated":"Sprint Bioscience \/ Day One Biopharmaceuticals"},{"orgOrder":0,"company":"Sprint Bioscience","sponsor":"Deciphera Pharmaceuticals","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"SWEDEN","productType":"Other Small Molecule","year":"2021","type":"Licensing Agreement","leadProduct":"SB02024","moa":"VPS3A","graph1":"Oncology","graph2":"Preclinical","graph3":"Sprint Bioscience","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Sprint Bioscience \/ Deciphera Pharmaceuticals","highestDevelopmentStatusID":"4","companyTruncated":"Sprint Bioscience \/ Deciphera Pharmaceuticals"}]

    Find Clinical Drug Pipeline Developments & Deals by Sprint Bioscience

    Menu

    Sprint Bioscience

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Sprint Bioscience

                            Sweden arrow
                            India Med Expo
                            Not Confirmed

                            Sprint Bioscience

                            Sweden arrow
                            India Med Expo
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Sponsor : Day One Biopharmaceuticals

                            Deal Size : $316.0 million

                            Deal Type : Licensing Agreement

                            DEALS_DEV arrow-down

                            Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience

                            Details : Under the agreement, Day One receives an exclusive license to develop and commercialize small molecule drug candidates targeting Vaccinia-related kinase 1 (VRK1), for pediatric and adult cancers with high unmet need.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : $3.0 million

                            August 16, 2023

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Sponsor : Day One Biopharmaceuticals

                            Deal Size : $316.0 million

                            Deal Type : Licensing Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Sprint Bioscience

                            Sweden arrow
                            India Med Expo
                            Not Confirmed

                            Sprint Bioscience

                            Sweden arrow
                            India Med Expo
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : SB02024

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Sponsor : Deciphera Pharmaceuticals

                            Deal Size : $277.0 million

                            Deal Type : Licensing Agreement

                            DEALS_DEV arrow-down

                            Sprint Bioscience Licenses the Cancer Drug Program Vps34 to Deciphera Pharmaceuticals

                            Details : Sprint Bioscience lead compound SB02024 blocks the autophagy of tumor cells by inhibiting the protein Vps34. When autophagy is blocked, the tumor cells become visible to the immune system again.

                            Product Name : SB02024

                            Product Type : Other Small Molecule

                            Upfront Cash : $4.0 million

                            March 08, 2021

                            Lead Product(s) : SB02024

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Sponsor : Deciphera Pharmaceuticals

                            Deal Size : $277.0 million

                            Deal Type : Licensing Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Sprint Bioscience

                            Sweden arrow
                            India Med Expo
                            Not Confirmed

                            Sprint Bioscience

                            Sweden arrow
                            India Med Expo
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : SB02024

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Sprint Bioscience Publishes Scientific Study With New Positive Data from the Vps34 Program

                            Details : The research results show that SB02024 activates the immune system in tumors in malignant melanoma and colorectal cancer.

                            Product Name : SB02024

                            Product Type : Other Small Molecule

                            Upfront Cash : Inapplicable

                            April 30, 2020

                            Lead Product(s) : SB02024

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth